Skip to main content
Erschienen in: Pediatric Nephrology 4/2018

18.11.2017 | Original Article

Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease

verfasst von: Alice Monzani, Michela Perrone, Flavia Prodam, Stefania Moia, Giulia Genoni, Sara Testa, Fabio Paglialonga, Anna Rapa, Gianni Bona, Giovanni Montini, Alberto Edefonti

Erschienen in: Pediatric Nephrology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Impairment in orexigenic/anorexigenic hormone balance may be key in the pathogenesis of protein energy wasting in children with chronic kidney disease (CKD). Measurement of ghrelin and obestatin concentrations in children with CKD would help assess the potential contribution of these hormones to uremic protein energy wasting.

Methods

This was a cross-sectional case–control study. Acylated and unacylated ghrelin and obestatin were measured in 42 children on conservative treatment (CT), 20 children on hemodialysis, 48 pediatric renal transplant (RTx) recipients and 43 controls (CTR) (mean age 11.9, range 5–20 years). Weight, height and bicipital, tricipital, subscapular and suprailiac folds were measured, and the body mass index-standard deviation score (BMI-SDS), percentage of fat mass and fat-free mass were calculated. Urea and creatinine were measured and the glomerular filtration rate (GFR) calculated.

Results

Unacylated ghrelin level was higher in patients than controls (p = 0.0001), with the highest levels found in hemodialysis patients (p = 0.001 vs. CKD-CT, p = 0.0001 vs. RTx, p < 0.0001 vs. CTR). Obestatin level was significantly higher in patients on hemodialysis than those on conservative treatment, RTx recipients and controls (p < 0.0001 in each case). Unacylated ghrelin negatively correlated with weight-SDS (p < 0.0001), BMI-SDS (p = 0.0005) and percentage fat mass (p = 0.004) and positively correlated with percentage fat-free mass (p = 0.004). Obestatin concentration negatively correlated with weight-SDS (p = 0.007). Unacylated ghrelin and obestatin concentrations positively correlated with creatinine and urea and inversely with eGFR, even after adjustments for gender, age, puberty and BMI-SDS (p < 0.0001 for each model).

Conclusions

Unacylated ghrelin and obestatin, negatively related to renal function, seem to be promising inverse indicators of nutritional status in children with CKD. Potential therapeutic implications in terms of optimization of their removal in patients on hemodialysis could be hypothesized.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27:793–799CrossRefPubMed Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27:793–799CrossRefPubMed
2.
Zurück zum Zitat Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K (2011) Wasting in chronic kidney disease. J Cachex Sarcopenia Muscle 2:9–25CrossRef Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K (2011) Wasting in chronic kidney disease. J Cachex Sarcopenia Muscle 2:9–25CrossRef
3.
Zurück zum Zitat Ulinski T, Cochat P (2006) Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies. Pediatr Nephrol 21:903–909CrossRefPubMed Ulinski T, Cochat P (2006) Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies. Pediatr Nephrol 21:903–909CrossRefPubMed
4.
Zurück zum Zitat Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD, Thorner MO (2008) Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 93:1980–1987CrossRefPubMedPubMedCentral Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD, Thorner MO (2008) Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 93:1980–1987CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Delhanty PJ, Neggers SJ, van der Lely AJ (2012) Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol 167:601–608CrossRefPubMed Delhanty PJ, Neggers SJ, van der Lely AJ (2012) Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol 167:601–608CrossRefPubMed
7.
Zurück zum Zitat Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310:996–999CrossRefPubMed Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310:996–999CrossRefPubMed
8.
Zurück zum Zitat Trovato L, Gallo D, Settanni F, Gesmundo I, Ghigo E, Granata R (2014) Obestatin: is it really doing something? Front Horm Res 42:175–185CrossRefPubMed Trovato L, Gallo D, Settanni F, Gesmundo I, Ghigo E, Granata R (2014) Obestatin: is it really doing something? Front Horm Res 42:175–185CrossRefPubMed
9.
Zurück zum Zitat Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, Peteiro J, García-Naveiro R, García-Buela J (2004) Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:2095–2100CrossRefPubMed Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, Peteiro J, García-Naveiro R, García-Buela J (2004) Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 19:2095–2100CrossRefPubMed
10.
Zurück zum Zitat Iglesias P, Díez JJ, Fernández-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R (2006) Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 64:68–73CrossRef Iglesias P, Díez JJ, Fernández-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R (2006) Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 64:68–73CrossRef
11.
Zurück zum Zitat Barazzoni R, Zanetti M, Stulle M, Mucci MP, Pirulli A, Dore F, Panzetta G, Vasile A, Biolo G, Guarnieri G (2008) Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. Clin Nutr 27:142–149CrossRefPubMed Barazzoni R, Zanetti M, Stulle M, Mucci MP, Pirulli A, Dore F, Panzetta G, Vasile A, Biolo G, Guarnieri G (2008) Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. Clin Nutr 27:142–149CrossRefPubMed
12.
Zurück zum Zitat Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M (2005) Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis. Growth Hormon IGF Res 15:369–376CrossRef Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M (2005) Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis. Growth Hormon IGF Res 15:369–376CrossRef
13.
Zurück zum Zitat Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, Takaya K, Hosoda H, Kojima M, Kangawa K, Nakao K (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748–2752CrossRefPubMed Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, Takaya K, Hosoda H, Kojima M, Kangawa K, Nakao K (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748–2752CrossRefPubMed
14.
Zurück zum Zitat Mafra D, Guebre-Egziabher F, Cleaud C, Arkouche W, Mialon A, Drai J, Fouque D (2010) Obestatin and ghrelin interplay in hemodialysis patients. Nutrition 26:1100–1104CrossRefPubMed Mafra D, Guebre-Egziabher F, Cleaud C, Arkouche W, Mialon A, Drai J, Fouque D (2010) Obestatin and ghrelin interplay in hemodialysis patients. Nutrition 26:1100–1104CrossRefPubMed
15.
Zurück zum Zitat Muscaritoli M, Molfino A, Chiappini MG, Laviano A, Ammann T, Spinsanti P, Melchiorri D, Inui A, Alegiani F, Rossi Fanelli F (2007) Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 27:360–365CrossRefPubMed Muscaritoli M, Molfino A, Chiappini MG, Laviano A, Ammann T, Spinsanti P, Melchiorri D, Inui A, Alegiani F, Rossi Fanelli F (2007) Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 27:360–365CrossRefPubMed
16.
Zurück zum Zitat Büscher AK, Büscher R, Hauffa BP, Hoyer PF (2010) Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease. Pediatr Nephrol 25:2295–2301CrossRefPubMed Büscher AK, Büscher R, Hauffa BP, Hoyer PF (2010) Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease. Pediatr Nephrol 25:2295–2301CrossRefPubMed
17.
Zurück zum Zitat Nüsken KD, Gröschl M, Rauh M, Stöhr W, Rascher W, Dötsch J (2004) Effect of renal failure and dialysis on circulating ghrelin concentration in children. Nephrol Dial Transplant 19:2156–2157CrossRefPubMed Nüsken KD, Gröschl M, Rauh M, Stöhr W, Rascher W, Dötsch J (2004) Effect of renal failure and dialysis on circulating ghrelin concentration in children. Nephrol Dial Transplant 19:2156–2157CrossRefPubMed
18.
Zurück zum Zitat Arbeiter AK, Büscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF (2009) Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 24:643–646CrossRefPubMed Arbeiter AK, Büscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF (2009) Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 24:643–646CrossRefPubMed
19.
Zurück zum Zitat Naufel MF, Bordon M, de Aquino TM, Ribeiro EB, de Abreu Carvalhaes JT (2010) Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. Pediatr Nephrol 25:2477–2482CrossRefPubMed Naufel MF, Bordon M, de Aquino TM, Ribeiro EB, de Abreu Carvalhaes JT (2010) Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. Pediatr Nephrol 25:2477–2482CrossRefPubMed
20.
Zurück zum Zitat Aygen B, Dogukan A, Dursun FE, Aydin S, Kilic N, Sahpaz F, Celiker H (2009) Ghrelin and obestatin levels in end-stage renal disease. J Int Med Res 37:757–765CrossRefPubMed Aygen B, Dogukan A, Dursun FE, Aydin S, Kilic N, Sahpaz F, Celiker H (2009) Ghrelin and obestatin levels in end-stage renal disease. J Int Med Res 37:757–765CrossRefPubMed
21.
Zurück zum Zitat Borges N, Moraes C, Barros AF, Carraro-Eduardo JC, Fouque D, Mafra D (2014) Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease. J Ren Nutr 24:100–104CrossRefPubMed Borges N, Moraes C, Barros AF, Carraro-Eduardo JC, Fouque D, Mafra D (2014) Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease. J Ren Nutr 24:100–104CrossRefPubMed
22.
Zurück zum Zitat Lacquaniti A, Donato V, Chirico V, Pettinato G, Buemi M (2011) From chronic kidney disease to transplantation: the roles of obestatin. Regul Pept 171:48–52CrossRefPubMed Lacquaniti A, Donato V, Chirico V, Pettinato G, Buemi M (2011) From chronic kidney disease to transplantation: the roles of obestatin. Regul Pept 171:48–52CrossRefPubMed
23.
Zurück zum Zitat Eftekhari MH, Ranjbar-Zahedani M, Basiratnia M, Rezaianzadeh A, Faghih S (2015) Comparison of appetite-regulating hormones and body composition in pediatric patients in predialysis stage of chronic kidney disease and healthy control group. Iran J Med Sci 40:27–33PubMedPubMedCentral Eftekhari MH, Ranjbar-Zahedani M, Basiratnia M, Rezaianzadeh A, Faghih S (2015) Comparison of appetite-regulating hormones and body composition in pediatric patients in predialysis stage of chronic kidney disease and healthy control group. Iran J Med Sci 40:27–33PubMedPubMedCentral
24.
Zurück zum Zitat Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421CrossRefPubMed
25.
Zurück zum Zitat Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593CrossRefPubMed Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593CrossRefPubMed
26.
Zurück zum Zitat Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7:284–294CrossRefPubMed Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7:284–294CrossRefPubMed
27.
Zurück zum Zitat Siri WE (1961) Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A (eds) Techniques for measuring body composition. National Academy of Sciences, Washington, DC, pp 223–224 Siri WE (1961) Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A (eds) Techniques for measuring body composition. National Academy of Sciences, Washington, DC, pp 223–224
28.
Zurück zum Zitat Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
30.
Zurück zum Zitat Alberti C, Chevenne D, Mercat I, Josserand E, Armoogum-Boizeau P, Tichet J, Léger J (2011) Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clin Chem 57:1424–1435CrossRefPubMed Alberti C, Chevenne D, Mercat I, Josserand E, Armoogum-Boizeau P, Tichet J, Léger J (2011) Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clin Chem 57:1424–1435CrossRefPubMed
31.
Zurück zum Zitat Crist W, Napier-Phillips A (2001) Mealtime behaviors of young children: a comparison of normative and clinical data. J Dev Behav Pediatr 22:279–286CrossRefPubMed Crist W, Napier-Phillips A (2001) Mealtime behaviors of young children: a comparison of normative and clinical data. J Dev Behav Pediatr 22:279–286CrossRefPubMed
34.
Zurück zum Zitat Prodam F, Cadario F, Bellone S, Trovato L, Moia S, Pozzi E, Savastio S, Bona G (2014) Obestatin levels are associated with C-peptide and antiinsulin antibodies at the onset, whereas unacylated and acylated ghrelin levels are not predictive of long-term metabolic control in children with type 1 diabetes. J Clin Endocrinol Metab 99:E599–E607CrossRefPubMed Prodam F, Cadario F, Bellone S, Trovato L, Moia S, Pozzi E, Savastio S, Bona G (2014) Obestatin levels are associated with C-peptide and antiinsulin antibodies at the onset, whereas unacylated and acylated ghrelin levels are not predictive of long-term metabolic control in children with type 1 diabetes. J Clin Endocrinol Metab 99:E599–E607CrossRefPubMed
35.
Zurück zum Zitat Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, Furth SL, Warady BA (2014) Growth in children with chronic kidney disease: a report from the chronic kidney disease in children study. Pediatr Nephrol 29:1987–1995CrossRefPubMedPubMedCentral Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, Furth SL, Warady BA (2014) Growth in children with chronic kidney disease: a report from the chronic kidney disease in children study. Pediatr Nephrol 29:1987–1995CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Bonthuis M, van Stralen KJ, Verrina E, Groothoff JW, Alonso Melgar Á, Edefonti A, Fischbach M, Mendes P, Molchanova EA, Paripović D, Peco-Antic A, Printza N, Rees L, Rubik J, Stefanidis CJ, Sinha MD, Zagożdżon I, Jager KJ, Schaefer F (2013) Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrol Dial Transplant 28:iv195–iv204CrossRefPubMed Bonthuis M, van Stralen KJ, Verrina E, Groothoff JW, Alonso Melgar Á, Edefonti A, Fischbach M, Mendes P, Molchanova EA, Paripović D, Peco-Antic A, Printza N, Rees L, Rubik J, Stefanidis CJ, Sinha MD, Zagożdżon I, Jager KJ, Schaefer F (2013) Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrol Dial Transplant 28:iv195–iv204CrossRefPubMed
37.
38.
Zurück zum Zitat Haffner D, Zivicnjak M (2017) Pubertal development in children with chronic kidney disease. Pediatr Nephrol 32:949–964CrossRefPubMed Haffner D, Zivicnjak M (2017) Pubertal development in children with chronic kidney disease. Pediatr Nephrol 32:949–964CrossRefPubMed
39.
Zurück zum Zitat Otto B, Tschöp M, Heldwein W, Pfeiffer AF, Diederich S (2004) Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol 151:113–117CrossRefPubMed Otto B, Tschöp M, Heldwein W, Pfeiffer AF, Diederich S (2004) Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol 151:113–117CrossRefPubMed
40.
Zurück zum Zitat Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105:6320–6325CrossRefPubMedPubMedCentral Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105:6320–6325CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C (2007) Ghrelin interacts with human plasma lipoproteins. Endocrinology 148:2355–2362CrossRefPubMed De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C (2007) Ghrelin interacts with human plasma lipoproteins. Endocrinology 148:2355–2362CrossRefPubMed
42.
Zurück zum Zitat Gupta RK, Kuppusamy T, Patrie JT, Gaylinn B, Liu J, Thorner MO, Bolton WK (2013) Association of plasma des-acyl ghrelin levels with CKD. Clin J Am Soc Nephrol 8:1098–1105CrossRefPubMedPubMedCentral Gupta RK, Kuppusamy T, Patrie JT, Gaylinn B, Liu J, Thorner MO, Bolton WK (2013) Association of plasma des-acyl ghrelin levels with CKD. Clin J Am Soc Nephrol 8:1098–1105CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader–Willi syndrome. J Clin Endocrinol Metab 88:174–178CrossRefPubMed Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader–Willi syndrome. J Clin Endocrinol Metab 88:174–178CrossRefPubMed
44.
Zurück zum Zitat Prodam F, Monzani A, Ricotti R, Marolda A, Bellone S, Aimaretti G, Roccio M, Bona G (2014) Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents. J Clin Endocrinol Metab 99:1556–1568CrossRefPubMed Prodam F, Monzani A, Ricotti R, Marolda A, Bellone S, Aimaretti G, Roccio M, Bona G (2014) Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents. J Clin Endocrinol Metab 99:1556–1568CrossRefPubMed
45.
Zurück zum Zitat Rodriguez Ayala E, Pecoits-Filho R, Heimbürger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19:421–426CrossRefPubMed Rodriguez Ayala E, Pecoits-Filho R, Heimbürger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19:421–426CrossRefPubMed
46.
Zurück zum Zitat Foster-Schubert KE, Overduin J, Prudom CE, Liu J, Callahan HS, Gaylinn BD, Thorner MO, Cummings DE (2008) Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab 93:1971–1979CrossRefPubMedPubMedCentral Foster-Schubert KE, Overduin J, Prudom CE, Liu J, Callahan HS, Gaylinn BD, Thorner MO, Cummings DE (2008) Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab 93:1971–1979CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, Brown EA, Bloom SR, Choi P (2005) Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 16:2111–2118CrossRefPubMed Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, Brown EA, Bloom SR, Choi P (2005) Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 16:2111–2118CrossRefPubMed
48.
Zurück zum Zitat Ashby DR, Ford HE, Wynne KJ, Wren AM, Murphy KG, Busbridge M, Brown EA, Taube DH, Ghatei MA, Tam FW, Bloom SR, Choi P (2009) Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 76:199–206CrossRefPubMed Ashby DR, Ford HE, Wynne KJ, Wren AM, Murphy KG, Busbridge M, Brown EA, Taube DH, Ghatei MA, Tam FW, Bloom SR, Choi P (2009) Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 76:199–206CrossRefPubMed
49.
Zurück zum Zitat Rodríguez A, Gómez-Ambrosi J, Catalán V, Gil MJ, Becerril S, Sáinz N, Silva C, Salvador J, Colina I, Frühbeck G (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes 33:541–552CrossRef Rodríguez A, Gómez-Ambrosi J, Catalán V, Gil MJ, Becerril S, Sáinz N, Silva C, Salvador J, Colina I, Frühbeck G (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes 33:541–552CrossRef
50.
Zurück zum Zitat Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schürmann A, Szanto I, Tschöp MH, Rohner-Jeanrenaud F (2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116:1983–1993CrossRefPubMedPubMedCentral Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schürmann A, Szanto I, Tschöp MH, Rohner-Jeanrenaud F (2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116:1983–1993CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17:519–531CrossRefPubMed Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17:519–531CrossRefPubMed
52.
Zurück zum Zitat Fischbach M, Zaloszyc A, Laetitia H, Menouer S, Terzic J (2014) Why does three times per week hemodialysis provide inadequate dialysis for children? Hemodial Int 18:S39–S42CrossRefPubMed Fischbach M, Zaloszyc A, Laetitia H, Menouer S, Terzic J (2014) Why does three times per week hemodialysis provide inadequate dialysis for children? Hemodial Int 18:S39–S42CrossRefPubMed
Metadaten
Titel
Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease
verfasst von
Alice Monzani
Michela Perrone
Flavia Prodam
Stefania Moia
Giulia Genoni
Sara Testa
Fabio Paglialonga
Anna Rapa
Gianni Bona
Giovanni Montini
Alberto Edefonti
Publikationsdatum
18.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 4/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3840-z

Weitere Artikel der Ausgabe 4/2018

Pediatric Nephrology 4/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.